Improving Health Worldwide
At Randox, we’re into R&D. Over 16% of turnover is reinvested in research and development, and therefore, we have more new tests in development than any other diagnostic company.
As such, our research and development programme at Randox is continuously evolving to address the most pressing health issues – whether it be developing a new test for Alzheimer’s disease, working on a bladder cancer test to triage patients at the highest risk, or trialling a test with the ability to stratify Acute Myeloid Leukemia (AML) patients, to determine patient response before chemotherapeutic treatment.
We are committed to improving health worldwide and as such will continue to focus our R&D efforts where they are most needed. Because ultimately, it’s all about saving lives.
Highlighting important health issues
To bring our pioneering research directly to you, our customers, clients, and interested parties, each month we will be highlighting a new health issue on our website and social media platforms – discussing its prevalence, the impact and problems associated with the issue, the power of prevention, and how Randox is working to tackle the issue.
Click on each Health Theme below to find out more.